These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 8475476
1. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs. Iyer L, Koza M, Iqbal O, Calabria R, Fareed J. Thromb Res; 1993 Feb 01; 69(3):259-69. PubMed ID: 8475476 [Abstract] [Full Text] [Related]
3. [The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray]. Zhang YJ, Zhang Q, Hou JL, Wang XL, Chen MX. Yao Xue Xue Bao; 2006 Mar 01; 41(3):268-71. PubMed ID: 16759001 [Abstract] [Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes. Liu Y, Lu WL, Zhang X, Wang XQ, Zhang H, Zhang Q. Peptides; 2005 Mar 01; 26(3):423-30. PubMed ID: 15652649 [Abstract] [Full Text] [Related]
5. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P. J Am Coll Cardiol; 1993 Oct 01; 22(4):1080-8. PubMed ID: 8409044 [Abstract] [Full Text] [Related]
9. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats. Freund M, Cazenave JP, Courtney M, Degryse E, Roitsch C, Bernat A, Delebassée D, Defreyn G, Maffrand JP. Thromb Haemost; 1990 Apr 12; 63(2):187-92. PubMed ID: 2363120 [Abstract] [Full Text] [Related]
10. Pharmacokinetic studies with recombinant hirudin in dogs. Nowak G, Markwardt F, Fink E. Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Apr 12; 115(1-2):70-4. PubMed ID: 2459035 [Abstract] [Full Text] [Related]
11. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris. Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W. Eur Heart J; 1996 Aug 12; 17(8):1207-15. PubMed ID: 8869862 [Abstract] [Full Text] [Related]
14. A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding time. Schenk JF, Glusa E, Radziwon P, Butti A, Markwardt F, Breddin HK. Haemostasis; 1996 Aug 12; 26(3):140-9. PubMed ID: 8738588 [Abstract] [Full Text] [Related]
15. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization. Liu Y, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ, Zhou TY, Zhang Q. J Control Release; 2007 Feb 26; 117(3):387-95. PubMed ID: 17207884 [Abstract] [Full Text] [Related]
18. Investigation on recombinant hirudin via oral route. Cen X, Ni J, Tan T, Liu X, Li C, Chen J, Huang Y, Zhu S, Bi Q. Peptides; 2006 Apr 26; 27(4):836-40. PubMed ID: 16469415 [Abstract] [Full Text] [Related]